Lymphoma and Elevated Hemoglobin/Hematocrit
No, lymphoma does not typically cause elevated hemoglobin and hematocrit—in fact, the opposite is true: anemia (low hemoglobin) is a common and prognostically significant finding in lymphoma patients.
Lymphoma Characteristically Causes Anemia, Not Polycythemia
The overwhelming evidence demonstrates that lymphoma is associated with decreased, not increased, hemoglobin levels:
Anemia is a frequent finding at lymphoma diagnosis, particularly in Hodgkin lymphoma where it is usually mild (hemoglobin 10-12 g/dL) and displays characteristics of anemia of chronic disease due to abnormalities in iron metabolism 1
In diffuse large B-cell lymphoma (DLBCL), anemia (hemoglobin <10 g/dL) is an independent prognostic factor associated with worse progression-free survival and overall survival 2, 3
Hemoglobin levels below 120 g/L in DLBCL patients are associated with significantly worse overall survival (p=0.0133) 4
In Waldenström's macroglobulinemia (a type of lymphoma), disease-related hemoglobin levels <10 g/dL or platelet counts <100×10⁹/L are indications to start treatment 5
Mechanisms of Anemia in Lymphoma
The anemia associated with lymphoma occurs through several mechanisms:
Inflammatory cytokine production: IL-6 is frequently upregulated in Hodgkin lymphoma and strongly associated with hepcidin elevation, the main regulator of iron metabolism, resulting in iron restriction and anemia of chronic disease 1
Bone marrow infiltration: Though rare (<10% of cases in Hodgkin lymphoma), direct marrow involvement can cause cytopenias 1
Hemophagocytic lymphohistiocytosis (HLH): When lymphoma triggers HLH, cytopenias (including anemia) are characteristic features, not elevated blood counts 6
Clinical Pitfall: Consider Alternative Diagnoses
If you encounter a patient with both lymphoma and elevated hemoglobin/hematocrit, you must consider:
Polycythemia vera (PV): A separate myeloproliferative neoplasm characterized by elevated red cell mass, low serum erythropoietin levels, and specific bone marrow findings 7
Secondary polycythemia: Due to hypoxia from unrelated comorbid conditions (chronic lung disease, sleep apnea, smoking) 7
Concurrent but unrelated conditions: The patient may have two separate hematologic processes
Laboratory error or hemoconcentration: Verify with repeat testing and assess for dehydration
Prognostic Significance of Hemoglobin in Lymphoma
Lower hemoglobin levels consistently predict worse outcomes:
In DLBCL, anemia is an International Prognostic Index-independent prognostic factor (hazard ratio 2.4, p=0.04) 2
Adding hemoglobin level to established prognostic tools (IPI, R-IPI, NCCN-IPI) improves their predictive accuracy, with concordance indices increasing from 0.69-0.70 to 0.70-0.73 3
In primary CNS lymphoma, anemia (<12 g/dL in women, <13 g/dL in men) is an independent prognostic factor, and combining it with MSKCC score increases prediction accuracy from 0.6 to 0.67 8